Biometrics

Partnership agreement

by Mark Rowe

Fujitsu has entered a partnership agreement with the Hungarian biometrics company, BioSec Group Ltd, aiming to cover the EMEIA region. The partnership focuses on BioSec’s palm vein recognition-based products, which will be available in the Fujitsu product range, including BioSec’s physical access control-, IT security- and stadium security products.

Fujitsu will sell Budapest-based BioSec solutions in the EMEIA region, including the StadiumGuard for stadia. The firms describe the products as an alternative for passwords, PIN codes, keys, cards and tokens; as biometrics are something the user is, people do not have to remember passwords or search for keys and access cards.

According to BioSec, the future’s security is in our hands, more precisely in our veins, as our vein pattern is an absolutely unique physical characteristic, which provides “material” for secure authentication.

BioSec reports that it has been developing biometrics based on Fujitsu’s PalmSecure technology for almost a decade. Despite large numbers of people of different ages and abilities, BioSec says that its product has shown that high security should not compromise user experience. The product for example is in use at the Budapest University of Technology and Economics’s building Z.

Visit www.biosecgroup.com.

Related News

  • Biometrics

    Facial comparison

    by Mark Rowe

    Conor Hickey, Head of Solution Architecture, Agreement Automation, EMEA, at the US-based authentication product company OneSpan, looks at the future of facial…

  • Biometrics

    Software Version 22

    by Mark Rowe

    Access control manufacturer Inner Range has added to its flagship intelligent access and security system, Integriti. Software Version 22, which is now…

Newsletter

Subscribe to our weekly newsletter to stay on top of security news and events.

© 2024 Professional Security Magazine. All rights reserved.

Website by MSEC Marketing